Vivos Therapeutics (VVOS) Misses Q2 EPS by 60c

Vivos Therapeutics (NASDAQ: VVOS) reported Q2 EPS of ($0.60). Revenue for the quarter came in at $4.1 million.

For earnings history and earnings-related data on Vivos Therapeutics (VVOS) click here.

You May Also Be Interested In

• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
• Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
• Pharvaris B.V. (PHVS) PT Raised to $75 at Citizens: Has Cash Runway Into 2028